Don't Be Surprised to Dispense More Biosimilars

January 2020

You'll see use of biosimilars continue to expand.

There's been some hesitancy to use biosimilars...partly because they aren't exact copies of the brand or "reference" biologic.

But clinicians are warming up to biosimilars as experience with using them and evidence for their safety increases.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Injectables Prevent Cases of Mistaken Identity With IV Infusions
Transitions of Care Overcome Barriers to Medication Reconciliation in Critically Ill Patients
Biosimilars Don't Be Surprised to Dispense More Biosimilars
Med Safety Be Prepared to Troubleshoot OTC Meds Without Bar Codes
Opioids Think of Apadaz as Similar to Norco or Lortab for Acute Pain
Cultural Awareness Address Transgender and Gender-Diverse Patients Appropriately
Sleep Disorders Wakix Will Be a New Rx Med for Narcolepsy
Medication Errors Use Double Checks With Meds That Have Extended-Release Suffixes
Supplements Document "Natural" Cold and Flu Remedies on Med Histories